Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin

被引:71
作者
Evrard, B
Chiap, P
DeTullio, P
Ghalmi, F
Piel, G
Van Hees, T
Crommen, J
Losson, B
Delattre, L
机构
[1] Univ Liege, Inst Pharm, Lab Pharmaceut Technol, CHU Tour, B-4000 Liege 1, Belgium
[2] Univ Liege, Inst Pharm, Lab Drug Anal, B-4000 Liege 1, Belgium
[3] Univ Liege, CHU Tour, Lab Pharmaceut Chem, B-4000 Liege, Belgium
[4] Fac Med Vet, Parasitol Lab, B-4000 Liege, Belgium
关键词
albendazole; hydroxypropyl-beta-cyclodextrin; oral solution; bioavailability; veterinary dosage forms;
D O I
10.1016/S0168-3659(02)00270-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Albendazole (ABZ) is a benzimidazole derivative with a broad spectrum of activity against human and animal helminthe parasites. ABZ has a very poor aqueous solubility. This study shows that hydroxypropyl-p-cyclodextrin (HP-beta-CD) is able to form inclusion complexes with ABZ and that is able to increase its aqueous solubility. A synergistic effect exists between HP-beta-CD and citric acid. The combination of HP-beta-CD (200 mM) and citric acid (50 mM) allows dissolution of more than 1.5 ma of ABZ per ml. The aim of this study is the in vivo evaluation in sheep of a solution of the inclusion complex of ABZ with HP-beta-CD in comparison with a suspension of the same drug. A significant (P<0.05) increase in the relative bioavailability is obtained with the solution containing the ABZ-HP-beta-CD complex as measured by ABZSO plasma levels. The area under the curve (AUC(0-->proportional to)) of the solution is 37% higher than that obtained with the suspension. Likewise the peak plasma concentration (C-max) is twice that of the solution while the time to reach C-max (T-max) is reduced. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 29 条
[1]  
Bassani V.L., 1996, Proceedings of the Eighth International Symposium on Cyclodextrons, P321
[2]   BIOAVAILABILITY OF DIFFERENT BENZIMIDAZOLE VOLUME-DOSE FORMULATIONS IN SHEEP [J].
BENCHAOUI, HA ;
FUTTER, IJ ;
HOLTON, LL ;
GETTINBY, G ;
MCKELLAR, QA .
VETERINARY RECORD, 1995, 137 (07) :171-172
[3]   AN INTRAVENOUS TOXICITY STUDY OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN, A USEFUL DRUG SOLUBILIZER, IN RATS AND MONKEYS [J].
BREWSTER, ME ;
ESTES, KS ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 59 (03) :231-243
[4]   Determination of albendazole and its main metabolites in ovine plasma by liquid chromatography with dialysis as an integrated sample preparation technique [J].
Chiap, P ;
Evrard, B ;
Bimazubute, MA ;
de Tullio, P ;
Hubert, P ;
Delattre, L ;
Crommen, J .
JOURNAL OF CHROMATOGRAPHY A, 2000, 870 (1-2) :121-134
[5]   USE OF BENZIMIDAZOLE CHEMOTHERAPY IN HUMAN HELMINTHIASES - INDICATIONS AND EFFICACY [J].
COOK, GC .
PARASITOLOGY TODAY, 1990, 6 (04) :133-136
[6]   THERAPY FOR NEUROCYSTICERCOSIS - A REAPPRAISAL [J].
DELBRUTTO, OH ;
SOTELO, J ;
ROMAN, GC .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) :730-735
[7]   COMPARATIVE EFFECTS OF ANIONIC, NATURAL BILE-ACID SURFACTANTS AND MIXED MICELLES ON THE INTESTINAL-ABSORPTION OF THE ANTHELMINTIC ALBENDAZOLE [J].
DELESTAL, JL ;
ALVAREZ, AI ;
VILLAVERDE, C ;
PRIETO, JG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (2-3) :105-109
[8]  
Fromming KH., 1994, CYCLODEXTRINS PHARM
[9]   SIMULTANEOUS PHARMACOKINETIC MODELING OF A DRUG AND 2 METABOLITES - APPLICATION TO ALBENDAZOLE IN SHEEP [J].
GALTIER, P ;
ALVINERIE, M ;
STEIMER, JL ;
FRANCHETEAU, P ;
PLUSQUELLEC, Y ;
HOUIN, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (01) :3-10
[10]  
Gerloczy A., 1996, P 8 INT S CYCL, P515